SEATTLE, Oct. 23, 2012 – The U.S. Food and Drug Administration (FDA) is investigating a multistate outbreak of fungal meningitis and joint infections. It appears the outbreak is due to the contamination of an injectable steroid medication called methylprednisolone acetate produced by the New England Compounding Center (NECC). Swedish has never carried the methylprednisolone acetate product produced by NECC.
'Joint Replacement' posts
Information from Swedish on Multistate Fungal Meningitis Outbreak among Patients who Received Contaminated Steroid Injections
Swedish/Issaquah Adds Robotic-Assisted, Partial-Knee Replacement or ‘Resurfacing’ Procedure; Free Educational Seminars Scheduled for March 14, April 4
ISSAQUAH, WASH., March 6, 2012 – In 2010 the Swedish Orthopedic Institute (SOI) became the first facility in the Puget Sound area to perform MAKOplasty®, a new partial knee resurfacing procedure designed to treat early- to mid-stage osteoarthritis. This procedure, which may be a viable alternative to total knee replacement or traditional manual partial knee resurfacing, is now available at Swedish/Issaquah.
“We are really pleased we can offer Eastside residents access to this state-of-the-art technology,” said SOI-affiliated orthopedic surgeon Gregory Komenda, M.D., who is with Proliance Orthopaedic & Sports Medicine. “We believe MAKOplasty offers an alternative for osteoarthritis patients who have not responded to non-surgical treatments or non-steroidal anti-inflammatory medications.”